DNLI fund manager activity
Denali Therapeutics Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q4 2017 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 2,414,162 | $62,092,245 | 0.02% | Aug 4, 2026 |
| Polen Capital Management | Sold out | — | — | 0.00% | Aug 4, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 2,436,895 | $46,788,383 | 0.02% | May 5, 2026 |
| Polen Capital Management | Added | 65,301 | $1,253,779 | 0.01% | May 14, 2026 |